|
US5804396A
(en)
|
1994-10-12 |
1998-09-08 |
Sugen, Inc. |
Assay for agents active in proliferative disorders
|
|
MX9707453A
(es)
|
1995-03-30 |
1997-12-31 |
Pfizer |
Derivados de quinazolina.
|
|
GB9508538D0
(en)
|
1995-04-27 |
1995-06-14 |
Zeneca Ltd |
Quinazoline derivatives
|
|
GB9508565D0
(en)
|
1995-04-27 |
1995-06-14 |
Zeneca Ltd |
Quiazoline derivative
|
|
GB9508537D0
(en)
|
1995-04-27 |
1995-06-14 |
Zeneca Ltd |
Quinazoline derivatives
|
|
HU228446B1
(en)
|
1996-04-12 |
2013-03-28 |
Warner Lambert Co |
Kinazoline derivatives as irreversible inhibitors of protein-kinase, pharmaceutical compositions containing these compounds and use thereof
|
|
UA73073C2
(uk)
|
1997-04-03 |
2005-06-15 |
Уайт Холдінгз Корпорейшн |
Заміщені 3-ціанохіноліни, спосіб їх одержання та фармацевтична композиція
|
|
ZA986729B
(en)
|
1997-07-29 |
1999-02-02 |
Warner Lambert Co |
Irreversible inhibitors of tyrosine kinases
|
|
ZA986732B
(en)
|
1997-07-29 |
1999-02-02 |
Warner Lambert Co |
Irreversible inhibitiors of tyrosine kinases
|
|
TW436485B
(en)
|
1997-08-01 |
2001-05-28 |
American Cyanamid Co |
Substituted quinazoline derivatives
|
|
DE60137273D1
(de)
|
2000-10-20 |
2009-02-12 |
Eisai R&D Man Co Ltd |
Verfahren zur Herstellung von 4-Phenoxy chinolin Derivaten
|
|
JP4679517B2
(ja)
|
2003-07-23 |
2011-04-27 |
エグゼリクシス， インコーポレイテッド |
薬剤としてのアゼピン誘導体
|
|
PT2213661E
(pt)
|
2003-09-26 |
2011-12-15 |
Exelixis Inc |
Moduladores de c-met e métodos de uso
|
|
WO2006113546A2
(en)
|
2005-04-15 |
2006-10-26 |
Neogenix Oncology, Inc. |
Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
|
|
RU2494107C2
(ru)
|
2005-05-09 |
2013-09-27 |
Оно Фармасьютикал Ко., Лтд. |
Моноклональные антитела человека к белку программируемой смерти 1 (pd-1) и способы лечения рака с использованием анти-pd-1-антител самостоятельно или в комбинации с другими иммунотерапевтическими средствами
|
|
CN101316590B
(zh)
|
2005-11-07 |
2011-08-03 |
卫材R&D管理有限公司 |
血管生成抑制剂和c-kit激酶抑制剂的组合使用
|
|
BRPI0708615A2
(pt)
*
|
2006-03-07 |
2011-06-07 |
Array Biopharma Inc |
compostos de pirazol heterobicìclicos e métodos de uso
|
|
WO2008076415A1
(en)
*
|
2006-12-14 |
2008-06-26 |
Exelixis, Inc. |
Methods of using mek inhibitors
|
|
WO2009017838A2
(en)
*
|
2007-08-01 |
2009-02-05 |
Exelixis, Inc. |
Combinations of jak-2 inhibitors and other agents
|
|
EP2340244A4
(en)
|
2008-10-14 |
2012-07-25 |
Ning Xi |
COMPOUNDS AND APPLICATION PROCEDURES
|
|
CN102256493A
(zh)
*
|
2008-10-29 |
2011-11-23 |
迪赛孚尔制药有限公司 |
表现出抗癌活性和抗增殖活性的环丙烷酰胺及其类似物
|
|
EP2213686A1
(en)
|
2009-01-28 |
2010-08-04 |
Externautics S.p.A. |
Tumor markers and methods of use thereof
|
|
EP2214019A1
(en)
|
2009-01-28 |
2010-08-04 |
Externautics S.p.A. |
Tumor markers and methods of use thereof
|
|
UA108618C2
(uk)
|
2009-08-07 |
2015-05-25 |
|
Застосування c-met-модуляторів в комбінації з темозоломідом та/або променевою терапією для лікування раку
|
|
WO2011051271A2
(en)
|
2009-10-26 |
2011-05-05 |
Externautics S.P.A. |
Prostate tumor markers and methods of use thereof
|
|
EP2493916B1
(en)
|
2009-10-26 |
2016-06-08 |
Externautics S.p.A. |
Lung tumor markers and methods of use thereof
|
|
WO2011051277A1
(en)
|
2009-10-26 |
2011-05-05 |
Externautics S.P.A. |
Breast tumor markers and methods of use thereof
|
|
EP2494351B1
(en)
|
2009-10-26 |
2016-06-08 |
Externautics S.p.A. |
Colon and rectal tumor markers and methods of use thereof
|
|
EP2494361B2
(en)
|
2009-10-26 |
2019-01-09 |
Externautics S.p.A. |
Ovary tumor markers and methods of use thereof
|
|
US20120070368A1
(en)
|
2010-04-16 |
2012-03-22 |
Exelixis, Inc. |
Methods of Using C-Met Modulators
|
|
EP2383578A1
(en)
|
2010-04-30 |
2011-11-02 |
Externautics S.p.A. |
Tumor marker and methods of use thereof
|
|
WO2012006960A1
(en)
*
|
2010-07-14 |
2012-01-19 |
Zhejiang Beta Pharma Inc. |
NOVEL FUSED HETEROCYCLIC DERIVATIVES USEFUL AS c-MET TYROSINE KINASE INHIBITORS
|
|
US8664244B2
(en)
|
2010-09-12 |
2014-03-04 |
Advenchen Pharmaceuticals, LLC |
Compounds as c-Met kinase inhibitors
|
|
CN102093421B
(zh)
|
2011-01-28 |
2014-07-02 |
北京康辰药业有限公司 |
一种含磷取代基的喹啉类化合物及其制备方法、以及含有该化合物的药物组合物及其应用
|
|
CN102408411B
(zh)
|
2011-09-19 |
2014-10-22 |
北京康辰药业股份有限公司 |
一种含喹啉基的羟肟酸类化合物及其制备方法、以及含有该化合物的药物组合物及其应用
|
|
CA2886433C
(en)
|
2012-10-04 |
2022-01-04 |
Dana-Farber Cancer Institute, Inc. |
Human monoclonal anti-pd-l1 antibodies and methods of use
|
|
JP6742903B2
(ja)
|
2013-05-02 |
2020-08-19 |
アナプティスバイオ インコーポレイティッド |
プログラム死−１（ｐｄ−１）に対する抗体
|
|
US10359428B2
(en)
|
2013-06-14 |
2019-07-23 |
Externautics S.P.A. |
Tumor marker, monoclonal antibodies and methods of use thereof
|
|
KR20160093012A
(ko)
|
2013-11-05 |
2016-08-05 |
코그네이트 바이오서비시즈, 인코포레이티드 |
암 치료를 위한 체크포인트 억제제 및 치료제의 배합물
|
|
IL248408B
(en)
*
|
2014-04-25 |
2022-06-01 |
Exelixis Inc |
A method for treating adenocarcinoma of the lungs
|
|
CN104817497B
(zh)
*
|
2015-03-20 |
2017-03-08 |
南京众睿缘生物科技有限公司 |
一种炔代喹啉衍生物及其制备方法和用途
|
|
CN106279147A
(zh)
*
|
2015-05-21 |
2017-01-04 |
中国科学院上海药物研究所 |
一种吡啶并氮杂环化合物及其制备方法和用途
|
|
US20180009758A1
(en)
|
2015-06-29 |
2018-01-11 |
Ontogenesis, Llc |
Multi-Tyrosine Kinase Inhibitors Derivatives and Methods of Use
|
|
US20170342033A1
(en)
|
2015-06-29 |
2017-11-30 |
Ontogenesis, Llc |
Multi-Tyrosine Kinase Inhibitors Derivatives and Methods of Use
|
|
CN105797123A
(zh)
|
2016-05-18 |
2016-07-27 |
王超 |
一种治疗不孕不育的中药组合物
|
|
CN106400155A
(zh)
|
2016-08-31 |
2017-02-15 |
飞佛特种纺织品（宁波）有限公司 |
一种防老化阳光面料
|
|
CN107235896B
(zh)
|
2016-09-13 |
2019-11-05 |
上海翔锦生物科技有限公司 |
酪氨酸激酶抑制剂及其应用
|
|
US10800741B2
(en)
|
2017-02-07 |
2020-10-13 |
Ancureall Pharmaceutical (Shanghai) Co., Ltd. |
Quinoline compound, preparation method and medical use therefor
|
|
WO2018153293A1
(zh)
*
|
2017-02-27 |
2018-08-30 |
北京赛特明强医药科技有限公司 |
二噁烷并喹唑啉与二噁烷并喹啉类化合物及其制备方法与应用
|
|
SG11202005719UA
(en)
|
2017-12-20 |
2020-07-29 |
Angex Pharmaceutical Inc |
Carbamate and urea compounds as multikinase inhibitors
|
|
UA128476C2
(uk)
|
2018-01-26 |
2024-07-24 |
Екселіксіс, Інк. |
Сполуки для лікування кіназозалежних розладів
|
|
UA128348C2
(uk)
|
2018-01-26 |
2024-06-19 |
Екселіксіс, Інк. |
Сполуки для лікування кіназозалежних розладів
|